Non-Small Cell Carcinoma — Trials

Non-Small Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

6,756 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,752
Recruiting: 926
Ph III recruiting: 138
Growth YoY: +3.1%
Industry share: 44%
Top sponsor: AstraZeneca
Termination share: 38.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,045)

clinicaltrialsPublishedShowing 1,901–1,950 of 2,079 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06557096	CSF CTC-Capture-Guided EGFR-TKI and Bevacizumab Combination Therapy in EGFR-Mutant Advanced NSCLC	not yet recruiting	Early Phase 1	100	Second Affiliated Hospital of Nanchang UniversityOTHER	0	Aug 16, 2024	clinicaltrials
NCT04685070	Neoadjuvant HS-10296 (Almonertinib) Therapy for Potential Resectable Stage III EGFR Mutation-Positive Non-small Cell Lung Cancer	active not recruiting	Phase 2	56	Shanghai Pulmonary Hospital, Shanghai, ChinaOTHER	1